Former Chief Commercial Officer · STANDARD BIOTOOLS INC. (LAB)

Steven McPhail

A named executive officer of STANDARD BIOTOOLS in every fiscal year CompBrief holds from FY2016 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$896,804

Salary $353,390Stock awards $200,665Bonus $120,946

FY2017: $775,397

5th of 5 named executive officers at Standard Biotools by FY2018 total.

5 named officers on file for STANDARD BIOTOOLS, FY2018

Steven McPhail’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • LAB’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how STANDARD BIOTOOLS’s whole pay program stands against its peers

  • STANDARD BIOTOOLS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on LAB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2019 (DEF 14A).

Free

Get Steven McPhail’s full pay file as a PDF — free

More than this page: up to 10 years of Steven’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Steven McPhail compensation by year

STANDARD BIOTOOLS Summary Compensation Table · all 3 fiscal years held
In US dollars, as STANDARD BIOTOOLS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018
Salary$339,700$344,796$353,390
Bonus$0$0$120,946
Stock awards$92,820$126,588$200,665
Option awards$80,934$160,413$58,504
Non-equity incentive$0$141,600$161,298
Pension and deferred compensation$0$0$0
All other$2,000$2,000$2,000
Total$515,459$775,397$896,804

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: STANDARD BIOTOOLS INC. DEF 14A filed April 23, 2019, accession 0001144204-19-020746, and prior-year filings. Open the filing on EDGAR.

How this page was built: the STANDARD BIOTOOLS INC. filed document, accession 0001144204-19-020746. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2019.

$515K
$775K
$897K
FY16
FY17
FY18
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
RSU18,538$159,798—
RSU11,132$95,958—
PSU9,200$79,304—
RSU1,576$13,585—
RSU1,550$13,361—
Option24,465—$5.13
Option4,752—$5.13
Option5,961—$5.13
Option16,200—$6.33

Per the Outstanding Equity Awards at Fiscal Year-End table in STANDARD BIOTOOLS INC.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

STANDARD BIOTOOLS’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Stephen LinthwaitePresident and CEO$2,585,213
Vikram JogChief Financial Officer$1,125,539
Nicholas KhadderSenior Vice President, General Counsel, and Corporate Secretary$1,091,461
Bradley KregerSenior Vice President, Global Operations$995,197
Steven McPhail · this pageFormer Chief Commercial Officer$896,804

The full STANDARD BIOTOOLS compensation record

free company brief

This page is one person within STANDARD BIOTOOLS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are STANDARD BIOTOOLS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Steven McPhail's compensation dossier · One-time report. No refunds.